UNRESECTABLE BREAST CANCER
Clinical trials for UNRESECTABLE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE BREAST CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat breast cancer: real-world study launches
Disease control Recruiting nowThis study follows about 1,155 adults with HER2-low breast cancer that cannot be removed by surgery or has spread to other parts of the body. It compares how long people stay on a newer targeted drug (trastuzumab deruxtecan) versus standard chemotherapy before needing a different…
Matched conditions: UNRESECTABLE BREAST CANCER
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
Blood test could help personalize breast cancer therapy
Disease control Recruiting nowThis study is for people with a certain type of advanced breast cancer (HR+ HER2-). It uses a blood test to measure a marker called TKa early in treatment. If the marker doesn't drop enough, doctors may switch to a different therapy sooner. The goal is to see if this approach hel…
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New hope for Hard-to-Treat breast cancer: targeted combo shows promise
Disease control Recruiting nowThis study tests a combination of two targeted drugs, tucatinib and trastuzumab, in people with a specific type of advanced breast cancer (HER3-mutant, HER2-negative) that has not responded to at least two prior chemotherapies. The goal is to see if this treatment can shrink tumo…
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 14, 2026 12:03 UTC